Atlas Trials

A Study to Evaluate Efficacy and Safety of HB0043 in Aadult Patients With Moderate to Severe Acne Vulgaris.

Clinical trial NCT07449156 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07449156
Sponsor
Shanghai Huaota Biopharmaceutical Co., Ltd.
Status
NOT_YET_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Acne Vulgaris
Start date
2026-03-27
Primary completion
2026-10-27
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.